Sigma-Aldrich to distribute isotopically labelled compounds
Sigma-Aldrich has entered into an exclusive agreement with IsoSciences LLC to distribute isotopically labelled bioactive compounds and their metabolites through its Aldrich division.
Sigma-Aldrich has entered into an exclusive agreement with IsoSciences LLC to distribute isotopically labelled bioactive compounds and their metabolites through its Aldrich division.
IsoSciences, a leading stable isotope company, provides a wide array of biological compounds and custom synthesis products. Aldrich, provider of ISOTEC Stable Isotopes, is a leader in manufacturing and providing stable isotope products for biomolecular NMR, proteomics, metabolic and MRI research.
Under the terms of the agreement, IsoSciences will be the exclusive provider to Aldrich for their stable isotope products listed in the agreement. These products include deuterated, 13C and 15N labelled vitamins, steroids, and other bioactive compounds used in metabolic research.
Nutrition and metabolic research investigates the relationships among diet, health and diseases by nutrient interactions with various metabolic pathways, bioavailability and nutrient analysis. These stable isotope products will be an addition to the extensive list of unlabeled bioactive compounds provided by Sigma-Aldrich.
"A new partnership with IsoSciences will allow Sigma-Aldrich to provide new stable isotope product lines to support our customers' research," said Dr C.T. Tan, ISOTEC Stable Isotope's r&d manager. "This collaboration offers a new range of labelled bioactive compounds for our ever expanding customer base."
"We have invested heavily in synthesising difficult-to-prepare, yet vitally needed, isotopically labelled standards," said David Saunders, president of IsoSciences, LLC.
IsoSciences' ceo Dr Scott W. Landvatter, said: "Our partnership with Sigma-Aldrich will allow us the widest possible distribution of our unique stable isotope labelled compounds to scientists worldwide."